|
Ruiz-Nodar JM, Marín F, Manzano-Fernández S, Valencia-Martín J, Hurtado JA, Roldán V, Pineda J, Pinar E, Sogorb F, Valdés M, Lip GY. An evaluation of the CHADS? stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest. 2011 Jun;139(6):1402-9. doi: 10.1378/chest.10-1408. Epub 2010 Sep 23. PubMed PMID: 20864616.
AÑO: 2011; IF: 5.25
|
20864616
|
Marín F, Roldán V, Martínez JG, Hernández-Madrid A, Hernández-Romero D, Ortego M, Ibáñez A, Marín-Marín I, Navarro X, Lip GY, Moro C. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. Thromb Res. 2011 Oct;128(4):391-4. doi: 10.1016/j.thromres.2011.05.022. Epub 2011 Jun 26. PubMed PMID: 21708399.
AÑO: 2011; IF: 2.44
|
|
Teruel R., Pérez-Sánchez C., Corral J., Herranz M.T., Pérez-Andreu V., Saiz E., García-Barberá N., Martínez-Martínez I., Roldán V., Vicente V., López-Pedrera C., Martínez C. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. October 2011. 9:1985-1992. 10.1111/j.1538-7836.2011.04451.x
AÑO: 2011; IF: 5.731
|
|
Lip GY, Durrani OM, Roldan V, Lip PL, Marin F, Reuser TQ. Peri-operative management of ophthalmic patients taking antithrombotic therapy. Int J Clin Pract. 2011 Mar;65(3):361-71. doi: 10.1111/j.1742-1241.2010.02538.x. Review. PubMed PMID: 21314873.
AÑO: 2011; IF: 2.415
|
|
Montoro-García S., Marín F., Roldán V., Lip G.Y.H. Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?. Thrombosis Research. December 2011. 128:601-602. 10.1016/j.thromres.2011.07.005
AÑO: 2011; IF: 2.44
|